Bioequivalence tests getting stimulated

Published: 2003-03-17 06:57:00

Updated: 2003-03-17 06:57:00

The Korea Food and Drug Administration said that average 10 items are under bioequivalence tests during this month and frequent enquires on these tests are being made from drug manufacturing firms, which is stimulated by the new government's strong policy to provide the incentives for bioequivale...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK